Applied DNA Sciences : Launches Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel to Boost SARS-CoV-2 Variant Detection and Tracking Nationally
Message : Required fields Positioned as Screening Platform for Efficient Use of Private, State and Federal Next Generation Sequencing (NGS) Resources to Enhance Variant Testing Newly Developed PCR Panel Detects Specific Mutations to Focus Limited NGS Capacity on Most Impactful Variants of SARS-CoV-2 Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the launch of its Linea™ COVID-19 Selective Genomic Surveillance™ (SGS) Mutation Panel (the “SGS Panel”) to enhance the utility of limited N...
Source: marketscreener.com